Genetic Determinants of Bone Mass
Authors:
- Laura AudíLALaura Audí
- Marta García-RamírezMGMarta García-Ramírez
- Antonio CarrascosaACAntonio Carrascosa
- 1 March 1999
- journal article
- review article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 51 (3) , 105-123
Abstract
A genetic contribution to bone mass determination was first described in the early 70s. Elucidation of gene contribution to this has since been attempted through studies analyzing associations between bone mass acquisition and/or maintenance and polymorphic variations of several genes. The first to be described was the vitamin D receptor gene (VDR), initially claimed to contribute to almost 75% of the genetic variation in bone mineral density (BMD) in twin and general population studies. Not all of the studies published to date conclude that a clear relationship exists between polymorphic VDR alleles and BMD, and the molecular basis for the VDR gene polymorphisms influence on bone mineralization has not yet been clarified. Since then, other genes with a significant role in bone metabolism such as estradiol receptor, collagen type 1α1, TGF-β1, interleukin-6, calcitonin receptor, α2-HS-glycoprotein, osteocalcin, calcium-sensing receptor, interleukin-1 receptor antagonist, β3-adrenergic receptor, apolipoprotein E, PTH, IGF-I and glucocorticoid receptor have been analyzed. Some polymorphic variations in these genes have been associated in some works with significant differences in BMD, with even more significant contributions when associations of different gene polymorphisms were analyzed. Again, the molecular basis for the contribution of these alleles to bone mass determination has not yet been described. A different approach has been attempted by linkage analysis of loci involved in bone density in pedigrees with low BMD using BMD as a quantitative trait. Recent results do not confirm, in these families, any association with any of the previously reported genes, but rather with other as yet unidentified genes. The genetic contribution to mild variations in the general population, as a result of environmental and endogenous individual influences, probably differs completely from that providing a pathologic BMD.Keywords
This publication has 27 references indexed in Scilit:
- Association Between Serum Insulin Growth Factor-I (IGF-I) and a Simple Sequence Repeat in IGF-I Gene: Implications for Genetic Studies of Bone Mineral DensityThe Journal of Clinical Endocrinology & Metabolism, 1998
- THE GENETICS OF OSTEOPOROSIS: Vitamin D Receptor PolymorphismsAnnual Review of Nutrition, 1998
- A Polymorphism in the Glucocorticoid Receptor Gene May Be Associated with an Increased Sensitivity to Glucocorticoids in VivoThe Journal of Clinical Endocrinology & Metabolism, 1998
- From what will we die in 2020?The Lancet, 1997
- Molecular evidence for human alpha2-HS glycoprotein (AHSG) polymorphismHuman Genetics, 1996
- Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 geneNature Genetics, 1996
- Association of Estrogen Receptor Dinucleotide Repeat Polymorphism with OsteoporosisBiochemical and Biophysical Research Communications, 1995
- Lack of a high prevalence of the BB vitamin D receptor genotype in severely osteoporotic womenThe Journal of Clinical Endocrinology & Metabolism, 1995
- Aromatase in bone cell: Association with osteoporosis in postmenopausal womenThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Genetic determinants of bone mineral content at the spine and radius: A twin studyBone, 1987